🔴 Chemours is trading 9.4% down today on soft Q3 guidance and refrigerant inventory headwinds

Chemours is trading 9.4% down at $16.25 following its Q2 2026 earnings report, which featured a revenue miss and cautious forward guidance.

• Management issued Q3 Adjusted EBITDA guidance below Q2 levels, citing significant headwinds from refrigerant inventory levels.
• The company reported continued GAAP net losses for the quarter, though it highlighted growth in specialty segments like data centers and semiconductors.
• The stock is under pressure as the market reacts to the sequential EBITDA decline despite pockets of strength in high-growth end markets.